TNF, tumor necrosis factor, 7124

N. diseases: 340; N. variants: 9
Source: CURATED ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Biomarker phenotype CTD_human Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha. 21984482 2012
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Therapeutic phenotype CTD_human Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha. 21984482 2012
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Therapeutic phenotype CTD_human Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood. 20623750 2011
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Biomarker phenotype CTD_human Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood. 20623750 2011
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Biomarker phenotype CTD_human Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity. 19638433 2009
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Therapeutic phenotype CTD_human Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity. 19638433 2009
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Biomarker phenotype CTD_human Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. 17709330 2007
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Therapeutic phenotype CTD_human Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. 17709330 2007
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Biomarker phenotype CTD_human Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. 9696492 1998
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Therapeutic phenotype CTD_human Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. 9696492 1998
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Biomarker phenotype CTD_human Antioxidative roles of metallothionein and manganese superoxide dismutase induced by tumor necrosis factor-alpha and interleukin-6. 7532385 1995
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.350 Therapeutic phenotype CTD_human Antioxidative roles of metallothionein and manganese superoxide dismutase induced by tumor necrosis factor-alpha and interleukin-6. 7532385 1995